ASSESSMENT OF THE SAFETY OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY IN PATIENTS WITH HIV INFECTION

ACHILOVA Matlyuba Mirkhamzaevna, SHODIEVA Dilafruz Abdujalolovna

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali · 2024-yil

Annotatsiya

In this study, we investigated the safety of highly active antiretroviral therapy in HIV-infected patients. It is shown that as a result of the ineffectiveness and / or as a result of side effects of this therapy in 10.6% cases discontinued therapy performed or replacement regimens. One side effects of antiretroviral drugs - anemia occurs in 20.0% of HIV-infected patients and is often encountered when using regimens, containing azidotividin (AZT). In 8.5% of cases, the procedure has been changed due to the development of diarrheal syndrome. In addition, as the side effects of antiretroviral drugs developed lipodystrophy, peripheral neuropathy, and an increase of alanineaminotransferase activity.

Maqola ma’lumotlari
MualliflarACHILOVA Matlyuba Mirkhamzaevna, SHODIEVA Dilafruz Abdujalolovna
JurnalJournal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali
Nashr sanasi2024-06-15
Jild9
Son2
TilO‘zbek

Kalit so‘zlar

inson immunitet tanqisligi virusi, yuqori faol antiretrovirus terapiya, virus yuklamasi, nukleotid va nukleozid bo'lmagan teskari transkriptaza inhibitori, human immunodeficiency virus, highly active antiretroviral therapy, viral load, nucleotide and non-nucleoside reverse transcriptase inhibitor, inson immunitet tanqisligi virusi, yuqori faol antiretrovirus terapiya, virus yuklamasi, nukleotid va nukleozid bo'lmagan teskari transkriptaza inhibitori

Ilmiy soha

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali jurnalidan boshqa maqolalar

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali — barcha maqolalar